Fieldpoint Private Securities’s Quest Diagnostics DGX Stock Holding History

Fieldpoint Private Securities’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$7K	Buy	49 +25	+104%	+$3.41K	﹤0.01%	812
2022 Q1	$3K	Hold	24	–	–	﹤0.01%	1392
2021 Q4	$4K	Hold	24	–	–	﹤0.01%	1313
2021 Q3	$3K	Hold	24	–	–	﹤0.01%	1365
2021 Q2	$4K	Hold	24	–	–	﹤0.01%	1252
2021 Q1	$3K	Hold	24	–	–	﹤0.01%	1302
2020 Q4	$3K	Buy	+24	New	+$2.93K	﹤0.01%	1228

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Fieldpoint Private Securities's DGX Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Quest Diagnostics (DGX) stake by 104% in Q2 2022, buying an estimated $3.41K and bringing the position to 49 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Fieldpoint Private Securities first reported a position in DGX in Q4 2020 and has held it in 7 quarters since. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

Fieldpoint Private Securities held 49 shares of Quest Diagnostics worth $7K as of Q2 2022.
Fieldpoint Private Securities bought 25 Quest Diagnostics shares in Q2 2022, an estimated $3.41K.
Quest Diagnostics made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #812 holding.
Fieldpoint Private Securities first reported a position in Quest Diagnostics in Q4 2020 and has held it in 7 quarters since.
850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.